Severe asthma refractory to treatment: Concepts and realities;Asma grave y resistente al tratamiento: Conceptos y realidades

Archivos de Bronconeumologia

Volumn 42, Issue SUPPL.1, 2006, Pages 20-25

  López Viña, Antolín ^a,b  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b NONE   (Spain)

Author keywords

Asthma control; Difficult to control asthma; Refractory asthma; Severe asthma

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; LONG ACTING DRUG; STEROID;

ASTHMA; COMORBIDITY; COST OF ILLNESS; DIAGNOSTIC ERROR; DISEASE CONTROL; DISEASE SEVERITY; HUMAN; MORBIDITY; PRESCRIPTION; REVIEW; RISK FACTOR;

EID: 34547699013     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1157/13097253     Document Type: Article

References (41)

1. López Viña A, Agüero Balbín R, Aller Álvarez JL, et al. Normativa para el asma de control difícil. Arch Bronconeumol. 2005;41:505-15.
2. American Thoracic Society. Proceedings of the ATS Workshop on refractory asthma. Current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med. 2000;162:2341-51.
3. Rabe KF, Vermiere PA, Soriano JB, et al. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J. 2000;16:802-7.
4. López Viña A, Cimas JE, Díaz Sánchez C, et al. A comparison of primary care physicans and pnermologists in the management of asthma in Spain: ASES study. Respir Med. 2003;97:872-81.
5. Perpiña M, Pellicer C, De Diego A, et al. Diagnostic valve of bronchial provocation test with methacholine in asthma. A Bayesian analysis approach. Chest. 1994;104:149-56.
6. Smith AD, Cowan JO, Filsell S, et al. Diagnosing asthma. Comparisons between exhaled nitric oxide measurements and convencional tests. Am J Respir Crit Care Med. 2004;169:473-8.
7. Dupont LJ, Demedts MG, Verleden GM. Prospective evaluation of validity of exhaled nitric oxide for the diagnosis of asthma. Chest. 2003;123:751-6.
8. Fabbri LM, Romagnoli M, Corbetta L, et al. Differences in airway inflammmation in pationts with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003;167:418-24.
9. Newman KB, Mason UG, Schmaling KB. Cilinical features of vocal card dysfunction. Am J Respir Crit Care Med. 1995;152:1382-6.
10. Newman KB, Dubester SN. Vocal cord dysfunction masquerador of asthma. Semin Respir Crit Care Med. 1994;15:161-7.
11. Andronopoulos MG, Gallivan KH. PYLM, PUCD, EPL, and irritable larynx syndrome: what are we taking about and how do we treat it? J Voice. 2000;14:607-18.
12. Christopher KL, Wood RP, Eckert RC. Vocal cord disfunction presenting as asthma. N Engl J Med. 1983;308:1566-70.
13. Ramirez RJ, Leon I, Rivera LM. Episodic laryngeal diskinesia: clinical and psychiatric characterization. Chest. 1986;90:716-21.
14. Gavin LA, Wamboldt M, Brugman S, et al. Psychological and family characteristics of adolescents with vocal cord dysfunction. J Asthma. 1998;35:409-17.
15. Perkner JJ, Fennelly KP, Balkissoon R, et al. Irritant associated vocal cord dysfunction. Occup Environ Med. 1998;40:136-43.
16. McFadden ER, Zawadski DK. Vocal cord dysfunction masquering as exercise induced asthma: a physiologic cause for "choking" during athletic activities. Respir Crit Care Med. 1996;153:942-7.
17. Rundell KW, Spiering BA. Inspiratory stridor in elite athletes. Chest. 2003;123:468-74.
18. Healley DE, Swift E. Paradoxical vocal cord dysfunction in an infant with stridor and gastroesophageal reflux. Int J Pediatr Otorhinolaryngol. 1996;34:149-51.
19. Morris MJ, Deal LE, Bean DR, et al. Vocal cord dysfunction in patients with exertional dyspnea. Chest. 1999;116:1676-82.
20. Perkins PJ, Morris MJ. Vocal cord dysfunction induced by methacholine challenge testing. Chest. 2002;122:1988-93.
21. Peters EJ, Hatley TK, Crater SE, et al. Sinus computed tomography scan and markers of inflammation in vocal cord dysfunction and asthma. Ann Allergy Asthma Inmunol. 2003;90:316-22.
22. Lewis RA, Howell JBL. Definition of hyperventilation syndrome. Bull Eur Phisiopathol Respir. 1986;22:201-5.
23. Van Dixhoorn J, Duivenvoorden HJ. Efficacy of Nijmegen Questionnaire in recognition of the hyperventilation syndrome. J Psychosom Res. 1985;29:199-206.
24. Hardonk HJ, Beumar HM. Hyperventilation syndrome. En: Vinken P, Bruyn G, editores. Handbook of Clinical Neurology. New York: North-Hollad; 1979. p. 309-60.
25. Millqvist E, Bende M, Lowhagen O. Sensory hyperreactivity - a posible mechanism underlying cough and asthma-like symptoms. Allergy. 1998;53:1208-12.
26. Ringsberg KC, Löwhagen O, Sivik T. Psychological differences between asthmatics and patients suffering from asthma-like condition, functional breathing disorder: a comparison between the two groups concerning personality, psychosocial and somatic parameters. Integr Physiol Behav Sci. 1993;28:358-67.
27. Löwhagen O. Functional respiratory disorders as significant differential diagnosis in asthma. Lakrtidningen. 1989;86:57-9.
28. Thomas M, McKinley RK, Freeman E, et al. Prevalence of dysfunctional breathing in patients treated for asthma in primary care: cross sectional survey. BMJ. 2001;322:1098-100.
29. Martínez Moragón E, Perpiñá Tordera, Belloch Fuster A, et al. Prevalencia del síndrome de hiperventilación en pacientes tratados en una consulta de neumología. Arch Bronconeumol. 2005;41:267-71.
30. McClean AN, Howells J, Chaudri G, et al. Use of the Nijmegen Hyperventilation questionnaire and hyperventilation provocation test in a hospital asthma clinic. Am J Respir Crit Care Med. 1999;159:A652.
31. Bousquet J, Cauwenberge P, Khaltaer N; Aria Workshop Group. Impact on asthma. Workshop report. J Allergy Clin Immunol. 2001;108:S147-334.
32. Leggett JJ, Johnston BT, Mills M, et al. Prevalence of gastroesophageal reflux in difficult asthma: relationship to asthma outcome. Chest. 2005;127:1097-8.
33. Yigla M, Tov N, Solomonov A, et al. Difficult-to-asthma and obstructive sleep apnea. J Asthma. 2003;40:865-71.
34. Ten Brinke A, Sterk PJ, Maselee AA, et al. Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J. 2005;26:812-8.
35. Tunnicliffe WS, Fletcher TJ, Hammond K, et al. Sensitivy and exposure to indoor allergens in adults with differing asthma severity. Eur Respir J. 1999;13:654-9.
36. Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ. 2004;328:434-40.
37. Mascia K, Haselkorn T, Deniz YM, et al for the TENOR Study Group. Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma. J Allergy Clin Immunol. 2005;116:970-5.
38. Le Moual N, Siroux V, Pin I, et al, for the Epidemiological Study on the Genetics and Environment of Asthma (EGEA). Asthma severity and exposure to occupational asthmogens. Am J Respir Crit Care Med. 2005;172:440-5.
39. Mapp CE, Boschetto P, Maestrelli P, et al. Occupational asthma. Am J Respir Crit Care Med. 2005;172:280-305.
40. Chaudhuri R, Livingston E, McMahon E, et al. Cigarrette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med. 2003;168:1308-11.
41. López Viña A. Actitudes para fomentar el cumplimiento terapéutico en asma. Arch Bronconeumol. 2005;41:334-40.